BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Precision NanoSystems Announces Collaboration Agreement with Evonik Canada for the Manufacturing of High Quality Nanomedicines

  Precision Nanosystems Inc. (PNI), announced that they have entered into a manufacturing collaboration agreement with Evonik Canada.

  May 31, 2018

   · 

  3 min read
• Biotech Beach

  Quidel Announces Private Exchange Transactions with Holders of its Convertible Senior Notes due 2020

  Quidel Corporation announced that it has entered into separate, privately negotiated exchange agreements with certain holders of its 3.25% Convertible Senior Notes due 2020

  May 31, 2018

   · 

  3 min read
• Drug Development

  Kaiku Health Follow-up Algorithm for Cancer Patients Treated With Immunotherapy Enters a Multi-center Clinical Trial

  A novel follow-up algorithm for cancer immunotherapy, developed by digital health company Kaiku Health, is undergoing clinical validation in a multi-center trial conducted at Oulu University Hospital, Turku University Hospital and Docrates Cancer Center in Finland.

  May 31, 2018

   · 

  1 min read
• Genetown

  Thrombolytic Science to Participate in 2018 BIO International Conference

  Thrombolytic Science, LLC announced that it will meet with potential partners at the 25th BIO International Conference from June 4th to June 7th in Boston, Mass.

  May 31, 2018

   · 

  2 min read
• Policy

  Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s work to mitigate shortages of intravenous drugs, shorten supply disruptions and better predict vulnerabilities

  Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s work to mitigate shortages of intravenous drugs, shorten supply disruptions and better predict vulnerabilities

  May 31, 2018

   · 

  9 min read
• FDA

  Medicrea Receives World’s First and Only FDA-Clearance to Market Patient-Specific Cages

  The Medicrea® Group announced that it has obtained the first and only 510(k) clearance from the U.S. Food & Drug Administration (FDA) to market patient-specific spinal cages through the extension of its UNiD™ technology to select from its IB3D™ range of 3D-printed titanium interbody devices.

  May 31, 2018

   · 

  4 min read
• Policy

  Idaho Law Voiding Pregnant Women’s Living Wills Is Unconstitutional, Groups Say

  Compassion & Choices and Legal Voice have filed a federal lawsuit on behalf of four Idaho women.

  May 31, 2018

   · 

  4 min read
• Drug Development

  Early Intervention of Hemorrhagic Stroke Trial Reaches 100 Patients

  More than 100 subjects are now enrolled in the ENRICH randomized controlled trial designed to compare the outcomes between early surgical intervention of clot removal using the minimally disruptive BrainPath® Approach (NICO Corporation) and the “watch and see” medical management standard of care.

  May 31, 2018

   · 

  2 min read
• Business

  Future Now Detox Earns Joint Commission Accreditation

  Future Now Detox is a proud recipient of Joint Commission Accreditation.

  May 31, 2018

   · 

  3 min read
• Biotech Beach

  Xencor to Present at Two Upcoming Investor Conferences

  Xencor, Inc. announced that company management will present at two upcoming conferences.

  May 31, 2018

   · 

  2 min read